ExoDx Prostate Test: Implications for Value-Based Care

Skip to main content

User account menu

My EPI-CE Documentation
Log in

Search

User account menu

My EPI-CE Documentation
Log in

Search

ExoDx Prostate Test: Implications for Value-Based Care

Webinar Apr 23, 2020

+49 89 416 17270
exosomedx.info@bio-techne.com
Exosome Diagnostics GmbH
Am Klopferspitz 19a
82152 Martinsried
Germany

Social navigation

Facebook
Twitter
LinkedIn

The EPI-CE test was developed by Exosome Diagnostics, Inc. according to the European Union directive for in-vitro diagnostic devices IVDD (98/79/EC) and the performance characteristics determined by Exosome Diagnostics, Inc. The test performance has been verified in Exosome Diagnostics GmbH's clinical laboratories in Martinsried, Germany. Exosome Diagnostics GmbH is accredited by Dakks to ISO 15189. Exosome Diagnostics and ExoDx are registered trademarks of Exosome Diagnostics, Inc.